FDA Drug Application (091326) for NARATRIPTAN by PADDOCK LLC

Back to FDA Applications sponsored by PADDOCK LLC

Application Number091326
Product Number001
FormTABLET;ORAL
DosageEQ 1MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNARATRIPTAN
Active IngredientNARATRIPTAN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient NARATRIPTAN HYDROCHLORIDE2


Back to FDA Applications sponsored by PADDOCK LLC